HGC Investment Management’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-800,000
Closed -$8.11M 396
2022
Q3
$8.11M Sell
800,000
-800,000
-50% -$8.06M 0.55% 47
2022
Q2
$16.1M Buy
1,600,000
+800,000
+100% +$8.06M 0.49% 52
2022
Q1
$8.09M Hold
800,000
0.48% 57
2021
Q4
$8.16M Buy
+800,000
New +$8.11M 0.5% 50

Other funds holding IQMDU

HGC Investment Management's IQMDU Position: Q4 2022 in Review

HGC Investment Management sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q4 2022, closing a stake of 800,000 shares — an estimated $8.11M sold.

HGC Investment Management first reported a position in IQMDU in Q4 2021 and held it in 4 quarters. The position peaked at $16.1M in Q2 2022. 13 funds tracked by Wall St. Rank hold IQMDU as of Q4 2022.

  • HGC Investment Management reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
  • HGC Investment Management sold 800,000 Intelligent Medicine Acquisition Corp. Unit shares in Q4 2022, an estimated $8.11M.
  • HGC Investment Management first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
  • HGC Investment Management's Intelligent Medicine Acquisition Corp. Unit position peaked at $16.1M in Q2 2022.
  • 13 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q4 2022.

Based on HGC Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.